Voyager Therapeutics Inc (VYGR) — Cash Flow Reinvestment Rate
Voyager Therapeutics Inc (VYGR) has a Cash Flow Reinvestment Rate of 1.67x as of March 2024, reinvesting $98.21 Million (capex $2.14 Million plus investments $-96.06 Million) from operating cash flow of $58.77 Million. Explore Voyager Therapeutics Inc (VYGR) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Voyager Therapeutics Inc Cash Flow Reinvestment Rate (2015–2023)
Historical reinvestment intensity for Voyager Therapeutics Inc across 3 annual periods. Also explore total assets of Voyager Therapeutics Inc for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Voyager Therapeutics Inc (2015–2023)
Year-by-year capital reinvestment analysis for Voyager Therapeutics Inc. For live market cap and broader valuation context, see VYGR stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 1.86x | $144.90 Million | $77.92 Million | $3.26 Million | ▼ -0.2% |
| 2019 | 1.86x | $90.65 Million | $48.67 Million | $7.72 Million | ▼ -60.5% |
| 2015 | 4.72x | $194.77 Million | $41.30 Million | $1.03 Million | — |